|
ZSCAN16 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.52770000000557E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.58320000004575E-06 |
| Normal-vs-Stage2 |
1.469990E-01 |
| Normal-vs-Stage3 |
9.924300E-03 |
| Normal-vs-Stage4 |
2.763800E-03 |
| Stage1-vs-Stage2 |
1.396200E-01 |
| Stage1-vs-Stage3 |
1.447410E-01 |
| Stage1-vs-Stage4 |
5.087800E-01 |
| Stage2-vs-Stage3 |
6.767600E-01 |
| Stage2-vs-Stage4 |
3.913400E-01 |
| Stage3-vs-Stage4 |
5.550800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.048480E-04 |
| Normal-vs-AfricanAmerican |
1.096160E-01 |
| Normal-vs-Asian |
1.22150000003707E-06 |
| Caucasian-vs-AfricanAmerican |
7.422600E-01 |
| Caucasian-vs-Asian |
1.783700E-03 |
| AfricanAmerican-vs-Asian |
3.403600E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.023300E-04 |
| Normal-vs-Female |
6.09859999999296E-05 |
| Male-vs-Female |
8.416200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.64900999999329E-05 |
| Normal-vs-Age(41-60Yrs) |
5.754900E-04 |
| Normal-vs-Age(61-80Yrs) |
1.171030E-01 |
| Normal-vs-Age(81-100Yrs) |
3.305900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.180200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.987800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.874400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.286000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.789000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.423800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.138200E-01 |
| Classical-VS-Follicular |
2.239400E-04 |
| Classical-VS-Other |
7.113200E-01 |
| Classical-VS-Normal |
1.17629999962787E-07 |
| Tall-VS-Follicular |
1.251010E-01 |
| Tall-VS-Other |
3.311200E-01 |
| Tall-VS-Normal |
2.574400E-02 |
| Follicular-VS-Other |
1.451590E-01 |
| Follicular-VS-Normal |
6.442600E-01 |
| Other-VS-Normal |
1.581200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.029800E-04 |
| Normal-vs-N1 |
1.781550E-04 |
| N0-vs-N1 |
9.900400E-02 |
|
|
